caffeine citrate has been researched along with Ductus Arteriosus, Patent in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheong, JLY; Doyle, LW | 1 |
| Choi, BM; Hwang, J; Kim, YS; Shin, JH | 1 |
| Bendel-Stenzel, E; Chhabra, R; Harper, B; Ku, L; Laughon, M; Moya, F; Payne, EH; Puia-Dumitrescu, M; Smith, PB; Soriano, A; Wade, KC; Zhao, J | 1 |
3 other study(ies) available for caffeine citrate and Ductus Arteriosus, Patent
| Article | Year |
|---|---|
Childhood respiratory outcomes after neonatal caffeine therapy.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Child; Citrates; Ductus Arteriosus, Patent; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Oxygen Inhalation Therapy | 2020 |
Hemodynamic Effects on Systemic Blood Flow and Ductal Shunting Flow after Loading Dose of Intravenous Caffeine in Preterm Infants according to the Patency of Ductus Arteriosus.
Topics: Administration, Intravenous; Birth Weight; Caffeine; Citrates; Ductus Arteriosus; Ductus Arteriosus, Patent; Echocardiography; Female; Gestational Age; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Male; Vena Cava, Superior | 2018 |
Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Cerebral Hemorrhage; Citrates; Ductus Arteriosus, Patent; Electronic Health Records; Enterocolitis, Necrotizing; Female; Gestational Age; Humans; Infant, Extremely Premature; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Intensive Care, Neonatal; Male; Multivariate Analysis; Off-Label Use; Treatment Outcome | 2019 |